In clinical trials, documents, data and applications are separate with no single source of truth. Imagine a world where a clinical trial protocol design can be done and implemented in days. This vision is becoming a reality with the use of smart templates to build trials and standards-based ontologies linking downstream systems while using data to build real-time patient journeys and budget insights.
Register for this webinar to get key learnings from co-developing and piloting a standards-based platform for modern trial designs.
Scott Chetham, PhD, CEO, Faro Health
Scott Chetham, PhD, is an experienced healthcare entrepreneur who is currently the CEO and co-founder of Faro Health. Scott leads the strategy for the Faro Health platform, which is designed to power clinical development by connecting data to decision making in a fundamentally new way. Previously, he was the Head of Clinical Research Operations and Data Management at Verily Life Sciences, formerly known as Google Life Sciences. This multifaceted strategic and operational role involved leading the clinical strategy, clinical teams, process development and operations for all clinical projects of the company, including Google and Google[x]. Scott has also served as a Venture Partner at Versant Ventures, CTO and Co-founder of Intersection Medical (sold to ImpediMed) and VP Clinical Affairs (ImpediMed). In these latter two roles, he was responsible for clinical research strategy and operations.
Steven R. Cummings, MD, Emeritus Professor of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco
Dr. Cummings is an internal medicine physician and emeritus Professor of Medicine, Epidemiology, and Biostatistics at the University of California, San Francisco who is known for his innovations in simplification of clinical trials and in virtual trials.
He is the Director of the San Francisco Coordinating Center, an academic CRO, which coordinated large multicenter cohort studies and clinical trials. He was the PI for several pivotal clinical trials that won FDA approval for most of the therapies used for osteoporosis. He is also the co-author of Designing Clinical Research, a standard textbook on how to design clinical research.
He has served for over a year as Innovator-in-Residence at Genentech-Roche where he studied the origin of complexity in clinical trial protocols and developed a Lean Design workshop for clinical teams that reduced the complexity of model schedules of assessment by over 30%.
In addition, starting over 20 years ago, Dr. Cummings co-designed and co-led the first fully virtual clinical trials including the REMOTE trial funded by Pfizer. He currently leads the largest — 3,500 person — treatment trial ever conducted in Parkinson’s disease that is being done entirely from home. He also published a comprehensive review of the virtual or disseminated trial method in 2021 in JAMA Internal Medicine.
Dr. Cummings has over 600 publications and was elected to the National Academy of Medicine in the National Academy of Sciences for his accomplishments in clinical research.
Who Should Attend?
- Clinical Operations
- Clinical Project/Program Leads
- Clinical Systems
- Clinical Research
- Study Optimisation
- Patient Insights
What You Will Learn
- Learn how clinical study teams can balance the complexity of modern trial designs with a patient’s first mission
- Discover innovative approaches to minimize patient burden and enhance site feasibility
- Utilize data driven insights to proactively identify areas of decentralization during the initial design of the protocol
- Discuss challenges and strategies for the current state of adoption of decentralized trials in research
- Explore the role of modern trial designs and the collaboration done by digital clinical design platforms
- Explore the role of collaborations in addressing common barriers in the research community
- Defining patient-centricity in clinical trials
Faro Health is bringing clinical trials into the digital age by helping teams manage and balance the complexity of modern trial designs through a cloud native platform. The Faro platform enables study teams to design complex clinical trials using small modular building blocks and combines that with data driven insights to orchestrate and automate operationally complex trials. Faro brings balance, centricity and flexibility to protocol development through automation and integration to downstream systems and vendors, ensuring they are always up to date and correctly configured. As a result, clinical trials using Faro are operationally efficient which avoid delays due to ambiguity and generate data that can be trusted.